维普中文期刊产品整合服务
109篇 您的检索式:作者名="TAT S"
    题名 作者 年代 出处 被引量
1Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: Prognosis and outcomes显示文摘AIM: To analyze the combined treatment of resection and intraoperative radiofrequency ablation (RFA) for multifocal hepatocellular carcinoma in terms of prognosis and surgical outcomes.METHODS: This study was a retrospective case comparison study using prospectively collected data. The study covered the period from April 2001 to December 2006. The data of 200 patients with histologically confirmed hepatocellular carcinoma were reviewed. Nineteen patients (17 men and 2 women) having received resection in combination with RFA were chosen as subjects of the study (the combination group). Fiftyfour patients (43 men and 11 women) having received resection alone were selected for comparison (the resection group). The two groups matched tumor number and tumor size, and all the patients in the two groups displayed no tumor rupture, major vascular involvement and distant metastasis. Their demographics, preoperative assessment, disease recurrence patterns, overall survival and diseasefree survival were compared.RESULTS: In the combination group, the medianage was 65 years (range, 3477 years), the median tumor number was 3 (range, 29), and the median tumor size was 6 cm (range, 1.214 cm). In the resection group, the median age was 51.5 years (range, 2780 years, P = 0.003), the median tumor number was 3 (range, 29, P = 0.574), and the median tumor size was 6 cm (range, 114 cm, P = 0.782). The two groups were similar in characteristics of tumors and comorbidities, and had comparable results in preoperative liver function tests. All patients had ChildPugh class A status. Bilobar involvement occurred in 14 patients (73.6%) in the combination group and 3 patients (5.5%) in the resection group (P = 0.04). Six patients (32%) in the combination group and 35 patients (65%) in the resection group underwent major hepatectomy. Thirteen patients (68%) in the combination group and 19 patients (35%) in the resection group underwent minor hepatectomy (P = 0.012). The combination group had fewer major resections (32% vs 65%, P = 0.012), less blood loss (400 vs 657 mL, P = 0.007), shorter operation time (270 vs 400 min, P = 0.001), and shorter hospital stay (7 vs 8.5 d, P = 0.042). The two groups displayed no major differences in surgical complications (15.8% vs 31.5%, P = 0.24), disease recurrence (63.2% vs 50%, P = 0.673), hospital mortality (5.3% vs 5.6%, P = 1), and overall survival (53 vs 44.5 mo, P = 0.496).CONCLUSION: Safe and effective for selected patients with multifocal hepatocellular carcinoma, the combination of resection and intraoperative RFA widens the applicability of surgical intervention for the disease.Tan To Cheung Kelvin K Ng Kenneth S Chok See Ching Chan Ronnie T Poon Chung Mau Lo Sheung Tat Fan 2010World Journal of Gastroenterology2010,16,24:14
2Transient interference excision in over-the-horizon radar using adaptive time-frequency analysis显示文摘Xin G Hongbo S Tat S Y 2005Geoscience and Remote Sensing IEEE Transactions on2005,43,4:1
3Self-assembled Nanocomposite of Organic-inorganic Hybrid显示文摘Hussein M Z B Zainal Z Tat O W S 2000Journal of Chemistry2000,16,2:1
4The molecular triad OPG/RANK/RANKL:involvement in the orchestration of pathophysiological bone remodeling显示文摘Theoleyre S Wittrant Y Tat SK 0,,06:1
5The production of fatty acid isopropyl esters and their use as a diesel engine fuel显示文摘Wang Paul S Tat Mustafa E Van Gerpen Jon 2005Journal of the American Oil Chemists'' Society2005,82,11:1
6The molecular triad OPG/RANK/RANKL: involvement in the or- chestration of pathophysiological bone remodeling 显示文摘Theoleyre S Wittrant Y Tat S K 2004Cytokine Growth Factor Rev2004,15,6:1
7Strontium rane- late inhibits key factors affecting bone remodeling in hu- man osteoarthritic subchondral bone osteoblasts 显示文摘Tat S K Pelletier J P Mineau F 2011Bone2011,49,3:1
8The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling显示文摘THEOLEYRE S WITTRANT Y TAT S K 2004Cytokine Growth Fact or Rev2004,15,:1
9An effective method for the oxidation of aminofurazans to nitro-fura- zans 显示文摘Novikova Tat'yana S Mel'nikova Tat'yana M Kharitonova Olga V 1994Mendeleev Commun1994,4,:1
10IL-6, RANKL, TNF-alpha/IL- 1: interrelations in bone resorption pathophysiology显示文摘Kwan Tat S Padrines M Theoleyre S 2004Cytokine Growth Factor Rev2004,15,:1
11An effective method for oxidation of aminofurazans to nitrofurazazs显示文摘Tatyana S Novikova Tat' yana M Mel' nikova 1994Mendeleeve communication1994,,:1
12The molecular triad OPG/RANK/ RANKL:involvement in the orchestration of pathophysiological bone re- modeling 显示文摘Theoleyre S Wittrant Y Tat SK 2004Cytokine Growth Factor Rev2004,15,7:1
13The production of fatty acid isopropyl esters and their use as a diesel engine fuel 显示文摘WANG P S TAT M E GERPEN J V 2005Journal of the American Oil Chemists Society2005,82,5:1
14Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1 显示文摘Voss CV Davies BS Tat S 2011Proc Natl Acad Sci U S A2011,108,19:1
15Design of lactide copolymers as biomaterials显示文摘Ouchi Tat S 2004Polym Chem2004,42,3:1
16The production of fatty acid isopropyl esters and their use as a diesel engine fuel 显示文摘WANG PAUL S TAT MUSTAFA E VAN GERPEN J 2005Journal of the American Oil Chemists'' Society2005,11,7:1
17The molecular triad OPG/RANK/RANKL:involvement in the orchestration of pathophysiological bone remodeling显示文摘Theoleyre S Wittrant Y Tat SK 2004Cytokine Growth Factor Rev2004,15,6:1
18Olanzapine and venous thromboembolism显示文摘Hagg S Tatting P Spigset O 2003Int Clin Psychopharmaco12003,18,5:1
1911-6, rankl, Tnf-alpha/il-1: Interrelations in bone resorption pathophysiology 显示文摘Kwan tat S Padfines M Theoleyre S 2004Cytokine Growth Factor Rev2004,15,1:1
20Assessing the role of the glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) three-finger domain in binding lipoprotein lipase显示文摘BEIGNEUX A P DAVIES B S TAT S 2011J Biol Chem2011,286,22:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费